Comparison of effectiveness and side effects of Brivaracetam and Levetiracetam in head injury patients
Not Applicable
- Conditions
- Health Condition 1: G409- Epilepsy, unspecified
- Registration Number
- CTRI/2023/11/059371
- Lead Sponsor
- Gmc neurosurgery dept goa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with Traumatic brain injury with following findings will be included in the study
Acute subdural hematoma
Compound depressed fracture with underlying contusions
Intracerebral hematoma
Diffuse axonal injury
Cerebral contusion
Traumatic subarachnoid hemorrhage
Patients with GCS equal and more than 5
Exclusion Criteria
Presence of Preexisting seizure disorder
Presence of Other pathological brain condition known to cause seizures
Patients with GCS less than 5
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare the efficacy and tolerability of LEV and BRV in patients with traumatic brain injury with risk of seizuresTimepoint: At one week of treatment
- Secondary Outcome Measures
Name Time Method Adverse effectsTimepoint: At 1 week 2week & 1 month